Back to Results
First PageMeta Content
Chemistry / Sulfones / Vismodegib / Basal-cell carcinoma / End point of clinical trials / Medicine / Oncology / Organochlorides


Long-Term Safety and Efficacy of Vismodegib in Patients With Advanced Basal Cell Carcinoma (aBCC): 18-Month Update of the Pivotal ERIVANCE BCC Study Aleksandar Sekulic,1 Michael R. Migden,2 Nicole Basset-Seguin,3 Claus G
Add to Reading List

Document Date: 2014-05-12 19:51:30

Open Document

File Size: 582,81 KB

Share Result on Facebook
UPDATE